212 related articles for article (PubMed ID: 17451692)
1. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G; Ozyurek SE; Uncu Y
Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
[TBL] [Abstract][Full Text] [Related]
2. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
[TBL] [Abstract][Full Text] [Related]
5. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
6. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
10. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
11. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
12. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
13. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
Carmina E; Lobo RA
Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
Romualdi D; Giuliani M; Draisci G; Costantini B; Cristello F; Lanzone A; Guido M
Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
[TBL] [Abstract][Full Text] [Related]
15. [Androgen response in women with polycystic ovary syndrome and hyperinsulinemia during stimulation with corticotrophin and inhibition with dexamethasone].
Espinosa de los Monteros A; Guerra de la Garza A; Barrón J; Parra A
Rev Invest Clin; 1996; 48(4):267-73. PubMed ID: 8966389
[TBL] [Abstract][Full Text] [Related]
16. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
17. Plasma adrenomedullin levels in patients with polycystic ovary syndrome.
Ucar B; Noyan V; Caglayan O; Yucel A; Sagsoz N
Fertil Steril; 2006 Oct; 86(4):942-8. PubMed ID: 16963041
[TBL] [Abstract][Full Text] [Related]
18. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.
Strowitzki T; Halser B; Demant T
Gynecol Endocrinol; 2002 Feb; 16(1):45-51. PubMed ID: 11915581
[TBL] [Abstract][Full Text] [Related]
19. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
[TBL] [Abstract][Full Text] [Related]
20. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
